Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Down 4.2% – Time to Sell?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) shares were down 4.2% during mid-day trading on Friday . The stock traded as low as $8.40 and last traded at $8.40. Approximately 531 shares were traded during trading, a decline of 99% from the average daily volume of 102,653 shares. The stock had previously closed at $8.77.

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

The company has a market cap of $14.67 billion, a price-to-earnings ratio of 13.47, a price-to-earnings-growth ratio of 2.04 and a beta of 0.20. The company has a current ratio of 6.44, a quick ratio of 5.74 and a debt-to-equity ratio of 0.01. The company has a fifty day moving average price of $8.41 and a two-hundred day moving average price of $8.57.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last issued its earnings results on Monday, October 27th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.16 by $0.02. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 11.90% and a net margin of 39.53%.The firm had revenue of $740.85 million during the quarter, compared to analysts’ expectations of $742.35 million. As a group, equities research analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current fiscal year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.